| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1817 | 2020 |
| Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a … PM Hoff, R Ansari, G Batist, J Cox, W Kocha, M Kuperminc, J Maroun, ... Journal of Clinical Oncology 19 (8), 2282-2292, 2001 | 1535 | 2001 |
| Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. G Batist, A Tulpule, BK Sinha, AG Katki, CE Myers, KH Cowan Journal of Biological Chemistry 261 (33), 15544-15549, 1986 | 1006 | 1986 |
| Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions O Felfoul, M Mohammadi, S Taherkhani, D De Lanauze, Y Zhong Xu, ... Nature nanotechnology 11 (11), 941-947, 2016 | 962 | 2016 |
| Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in … G Batist, G Ramakrishnan, CS Rao, A Chandrasekharan, J Gutheil, ... Journal of Clinical Oncology 19 (5), 1444-1454, 2001 | 836 | 2001 |
| Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and-sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated … TC Hamilton, MA Winker, KG Louie, G Batist, BC Behrens, T Tsuruo, ... Biochemical pharmacology 34 (14), 2583-2586, 1985 | 656 | 1985 |
| Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma L Harris, G Batist, R Belt, D Rovira, R Navari, N Azarnia, L Welles, E Winer, ... Cancer 94 (1), 25-36, 2002 | 647 | 2002 |
| Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk … W Miao, L Hu, PJ Scrivens, G Batist Journal of Biological Chemistry 280 (21), 20340-20348, 2005 | 597 | 2005 |
| Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial J Rodon, JC Soria, R Berger, WH Miller, E Rubin, A Kugel, A Tsimberidou, ... Nature medicine 25 (5), 751-758, 2019 | 424 | 2019 |
| Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. KH Cowan, G Batist, A Tulpule, BK Sinha, CE Myers Proceedings of the National Academy of Sciences 83 (24), 9328-9332, 1986 | 385 | 1986 |
| Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells AE Al Moustafa, MA Alaoui-Jamali, G Batist, M Hernandez-Perez, ... Oncogene 21 (17), 2634-2640, 2002 | 333 | 2002 |
| Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis L Yen, XL You, AE Al Moustafa, G Batist, NE Hynes, S Mader, S Meloche, ... Oncogene 19 (31), 3460-3469, 2000 | 321 | 2000 |
| Deficiency of connexin43 gap junctions is an independent marker for breast tumors DW Laird, P Fistouris, G Batist, L Alpert, HT Huynh, GD Carystinos, ... Cancer research 59 (16), 4104-4110, 1999 | 293 | 1999 |
| Systemic cancer therapy: achievements and challenges that lie ahead MO Palumbo, P Kavan, WH Miller Jr, L Panasci, S Assouline, N Johnson, ... Frontiers in pharmacology 4, 57, 2013 | 284 | 2013 |
| Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action BK Sinha, AG Katki, G Batist, KH Cowan, CE Myers Biochemistry 26 (13), 3776-3781, 1987 | 266 | 1987 |
| Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy V Cohen, V Panet-Raymond, N Sabbaghian, I Morin, G Batist, R Rozen Clinical cancer research 9 (5), 1611-1615, 2003 | 262 | 2003 |
| Use of statins and the risk of death in patients with prostate cancer O Yu, M Eberg, S Benayoun, A Aprikian, G Batist, S Suissa, L Azoulay J Clin Oncol 32 (1), 5-11, 2014 | 240 | 2014 |
| Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors G Batist, KA Gelmon, KN Chi, WH Miller Jr, SKL Chia, LD Mayer, ... Clinical Cancer Research 15 (2), 692-700, 2009 | 239 | 2009 |
| Mice: Role of glutathione G BouNoUsº, G Batist, P Gold Clin. Investig. Med 12, 154-161, 1989 | 220 | 1989 |
| The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor–positive metastatic breast cancer SA Wander, O Cohen, X Gong, GN Johnson, JE Buendia-Buendia, ... Cancer discovery 10 (8), 1174-1193, 2020 | 213 | 2020 |
